Intravascular infusions of soluble β-amyloid compromise the blood–brain barrier, activate CNS glial cells and induce peripheral hemorrhage
- 6 February 1999
- journal article
- Published by Elsevier BV in Brain Research
- Vol. 818 (1), 105-117
- https://doi.org/10.1016/s0006-8993(98)01143-3
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Brain Microvascular Changes in Alzheimer's Disease and Other DementiasaAnnals of the New York Academy of Sciences, 1997
- Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein ENature, 1997
- Effect of tumor necrosis factor-alpha on the permeability of bovine brain microvessel endothelial cell monolayers.Neurological Research, 1997
- Amyloid β‐Peptide Induces Cell Monolayer Albumin Permeability, Impairs Glucose Transport, and Induces Apoptosis in Vascular Endothelial CellsJournal of Neurochemistry, 1997
- Scavenging of Alzheimer's amyloid ?-protein by microglia in cultureJournal of Neuroscience Research, 1996
- Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disordersActa Neuropathologica, 1994
- Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes.Proceedings of the National Academy of Sciences of the United States of America, 1993
- β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's diseaseBrain Research, 1992
- Patterns of gliosis in alzheimer's disease and aging cerebrumGlia, 1989
- Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's diseaseCell, 1988